Home › Companies › ZEVRA THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ZEVRA THERAPEUTICS INC.’s Form 8-K, filed May 13, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 13, 2024: 6 items on ZEVRA THERAPEUTICS INC.’s Form 8-K, filed May 13, 2024: 5 passed (calculated) · 1 failed (calculated).
Significant dissent: 3 directors (41.8%, 28.4%, 22.2% against); 1 say-on-pay vote (53.0% support); 1 equity or compensation plan (80.4% against).
Notable dissent: 1 other board item (24.6% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024
Activist investors: Nantahala Capital (13F, 3.3%, as of September 30, 2026) · Mangless Daniel John (as of May 29, 2025)
Explore ZEVRA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are ZEVRA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Thomas D. Anderson | 15,266,761 | -- | -- | 6,062,268 | 9,865,186 | 72% | Passed (calculated) | — |
| Elect Director: Neil F. McFarlane | 12,413,828 | -- | -- | 8,915,201 | 9,865,186 | 58% | Passed (calculated) | — |
| Elect Director: Alvin Shih, M.D. | 16,592,152 | -- | -- | 4,736,877 | 9,865,186 | 78% | Passed (calculated) | — |
| 2. Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company ' s fiscal year ending December 31, 2024 | 22,543,306 | 7,352,086 | 1,298,823 | -- | -- | 75% | Passed (calculated) | — |
| 3. Approval, on an advisory and non-binding basis, of the compensation of the Company's named executive officers | 11,167,215 | 9,888,153 | 273,661 | -- | 9,865,186 | 53.0% | Passed (calculated) | — |
| 4. Approval of amendments to the Company's Amended and Restated 2014 Equity Incentive Plan | 4,143,728 | 16,964,060 | 221,241 | -- | 9,865,186 | 20% | Failed (calculated) | — |
Source: ZEVRA THERAPEUTICS INC., Form 8-K, filed with the SEC on May 13, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
104 asset managers disclosed a vote on at least one ZEVRA THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Alvin Shih, M.D.
ZEVRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alvin Shih, M.D.”): 16,592,152 for, 4,736,877 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 18,183 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,208,999 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Combines 3 wordings of this item as funds reported it.
58% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Neil F. McFarlane
ZEVRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Neil F. McFarlane”): 12,413,828 for, 8,915,201 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 58% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 18,183 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,208,999 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Combines 3 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Thomas D. Anderson
ZEVRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Thomas D. Anderson”): 15,266,761 for, 6,062,268 withheld, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 18,183 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,208,999 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Combines 2 wordings of this item as funds reported it.
20% Majority: no · of votes cast
Description as filed by funds: To approve amendments to the Company's Amended and Restated 2014 Equity Incentive Plan
ZEVRA THERAPEUTICS INC.’s own tally for this item (“4. Approval of amendments to the Company's Amended and Restated 2014 Equity Incentive Plan”): 4,143,728 for, 16,964,060 against, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Failed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a majority of the shares present or represented, the standard stated in the company’s proxy statement: votes for did not exceed votes against plus abstentions.
Support: 20% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 1,506,918 | 0 | 0 | Against |
| BlackRock | 0 | 787,245 | 0 | 0 | Against |
| Fidelity | 0 | 400,380 | 0 | 0 | Against |
| TIAA | 0 | 103,941 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 58,825 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 53,925 | 0 | 0 | Against |
| Charles Schwab | 0 | 44,534 | 0 | 0 | Against |
| Lincoln Financial | 0 | 29,400 | 0 | 0 | Against |
| Dimensional | 0 | 24,505 | 0 | 0 | Against |
| Global X | 0 | 19,072 | 0 | 0 | Against |
| American Century | 0 | 18,183 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 17,723 | 0 | 0 | Against |
| John Hancock | 0 | 16,121 | 0 | 0 | Against |
| Northern Trust | 0 | 15,732 | 0 | 0 | Against |
| State Street | 0 | 14,169 | 0 | 0 | Against |
| Pacific Life | 0 | 13,744 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 13,459 | 0 | 0 | Against |
| Voya | 0 | 12,873 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 12,510 | 0 | 0 | Against |
| Equitable | 0 | 9,762 | 0 | 0 | Against |
| Nationwide | 0 | 5,617 | 0 | 0 | Against |
| DWS | 0 | 5,319 | 0 | 0 | Against |
| Victory Capital | 0 | 5,024 | 0 | 0 | Against |
| Principal | 0 | 4,233 | 0 | 0 | Against |
| ProShares | 0 | 4,015 | 0 | 0 | Against |
Fund voting reports, all 33 managers: 3,208,999 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Combines 4 wordings of this item as funds reported it.
53.0% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials
ZEVRA THERAPEUTICS INC.’s own tally for this item (“3. Approval, on an advisory and non-binding basis, of the compensation of the Company's named executive officers”): 11,167,215 for, 9,888,153 against, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 53.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 0 | 18,183 | 0 | 0 | Against |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,187,952 for, 21,047 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Woodline Partners LP | 841,823 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 779,179 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 674,231 | 0 | 0 | 0 | For |
| State Street | 658,134 | 0 | 0 | 0 | For |
| BlackRock | 599,871 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 442,952 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 428,210 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
| Northern Trust | 157,596 | 19 | 0 | 0 | For |
| Wellington | 107,229 | 0 | 0 | 0 | For |
| Nuveen | 103,941 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 0 | 99,515 | 0 | 0 | Against |
| Point72 | 92,602 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 65,388 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,525 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 62,229 | 0 | 0 | 0 | For |
| Renaissance | 46,404 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| STRS OHIO | 30,900 | 0 | 0 | 0 | For |
| Rhumbline | 19,778 | 0 | 0 | 0 | For |
| Vanguard | 19,700 | 0 | 0 | 0 | For |
| Goldman Sachs | 54 | 19,354 | 0 | 0 | Against |
| American Century | 0 | 18,183 | 0 | 0 | Against |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| WASHINGTON STATE INVESTMENT BOARD | 16,116 | 0 | 0 | 0 | For |
Institutional-manager reports, all 84 managers: 5,710,676 for, 151,410 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024
ZEVRA THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company ' s fiscal year ending December 31, 2024”): 22,543,306 for, 7,352,086 against, per its Form 8-K filed May 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 75% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,506,918 | 0 | 0 | 0 | For |
| BlackRock | 787,245 | 0 | 0 | 0 | For |
| Fidelity | 400,380 | 0 | 0 | 0 | For |
| TIAA | 103,941 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 58,825 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 53,925 | 0 | 0 | 0 | For |
| Charles Schwab | 44,534 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,400 | 0 | 0 | 0 | For |
| Dimensional | 24,505 | 0 | 0 | 0 | For |
| Global X | 19,072 | 0 | 0 | 0 | For |
| American Century | 18,183 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 17,723 | 0 | 0 | 0 | For |
| John Hancock | 16,121 | 0 | 0 | 0 | For |
| Northern Trust | 15,732 | 0 | 0 | 0 | For |
| State Street | 14,169 | 0 | 0 | 0 | For |
| Pacific Life | 13,744 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 13,459 | 0 | 0 | 0 | For |
| Voya | 12,873 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 12,510 | 0 | 0 | 0 | For |
| Equitable | 9,762 | 0 | 0 | 0 | For |
| Nationwide | 5,617 | 0 | 0 | 0 | For |
| DWS | 5,319 | 0 | 0 | 0 | For |
| Victory Capital | 5,024 | 0 | 0 | 0 | For |
| Principal | 4,233 | 0 | 0 | 0 | For |
| ProShares | 4,015 | 0 | 0 | 0 | For |
Fund voting reports, all 33 managers: 3,208,999 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Altium Capital Management LP | 280,281 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 280,281 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 41,853,494 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.60% |
| 2 | BlackRock | 1.88% |
| 3 | Fidelity | 0.96% |
| 4 | TIAA | 0.25% |
| 5 | BRIDGEWAY FUNDS INC | 0.14% |
| 6 | QUANTITATIVE MASTER SERIES LLC | 0.13% |
| 7 | Charles Schwab | 0.11% |
| 8 | Lincoln Financial | 0.07% |
| 9 | Dimensional | 0.06% |
| 10 | Global X | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Woodline Partners LP | 2.01% |
| 2 | 683 Capital Management, LLC | 1.86% |
| 3 | Janney Montgomery Scott LLC | 1.61% |
| 4 | State Street | 1.57% |
| 5 | BlackRock | 1.43% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.06% |
| 7 | PNC BANK, NATIONAL ASSOCIATION | 1.02% |
| 8 | Altium Capital Management LP | 0.67% |
| 9 | Northern Trust | 0.38% |
| 10 | Wellington | 0.26% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 4,037,154 | 9.65% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 3,083,362 | 7.37% | Form 13F, quarter ended March 31, 2024 |
| Nantahala Capital Management, LLC | 2,453,405 | 5.86% | Proxy statement (DEF 14A), proxy filed April 3, 2024 |
| FMR (Fidelity) | 1,634,571 | 3.91% | Form 13F, quarter ended March 31, 2024 |
| Travis Mickle, Ph.D. | 817,212 | 1.95% | Proxy statement (DEF 14A), proxy filed April 3, 2024 |
| Geode Capital | 787,020 | 1.88% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 761,777 | 1.82% | Form 13F, quarter ended March 31, 2024 |
| State Street | 683,172 | 1.63% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 555,950 | 1.33% | Form 13F, quarter ended March 31, 2024 |
| JPMorgan Chase | 438,984 | 1.05% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 41,853,494 shares outstanding, as reported by ZEVRA THERAPEUTICS INC. on its Form 10-Q dated May 3, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ZEVRA THERAPEUTICS INC.'s shareholder meeting held May 13, 2024, in the 2023-2024 proxy season, 104 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 614 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — FOR was 53.0% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ZEVRA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 13, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ZEVRA THERAPEUTICS INC.’s 10-Q dated May 3, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ZEVRA THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page).
Proxy Votes Now, “ZEVRA THERAPEUTICS (ZVRA) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/zevra-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.